Shuren On US vs EU: FDA Strikes The Right Regulatory Balance
This article was originally published in Clinica
Executive Summary
While the medtech industry has often complained about how much longer it takes to get devices into the US compared with Europe, Jeff Shuren, director of the US FDA's device center thinks the agency has struck the right regulatory balance between public safety and an environment to allow innovation.